The value of immunohistochemistry on paraffin wax embedded tissue sections in the differentiation of small lymphocytic and mantle cell lymphomas

Journal of Clinical Pathology

Volumn 50, Issue 1, 1997, Pages 16-21

  Singh, N ^a   Wright, D H ^a  

^a SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

B small lymphocytic lymphoma; Cyclin D; Mantle cell lymphoma

Indexed keywords

CD20 ANTIGEN; CD23 ANTIGEN; CD3 ANTIGEN; CD5 ANTIGEN; CYCLIN D1; LEUKOSIALIN;

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL;

EID: 0031019587     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.50.1.16     Document Type: Article

References (33)

1. Banks PM, Chan J, Cleary ML, Delsol G, De Wolf-Peeters C, Gatter K, et al. Mantle cell lymphoma: A proposal for unification of morphologic, immunologic and molecular data. Am J Surg Pathol 1992;16:637-40.
2. Harris NL, Jaffe ES, Stein H, Banks PM, Chan KC, Cleary ML, et al. A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood 1994;84:1361-92.
3. Gerard-Marchant R, Hamlin I, Lennert K, Rilke F, Stansfeld AG, van Unnik JAM. Classification of non-Hodgkin's lymphomas. Lancet 1974;ii:406.
4. Perry D, Bast M, Armitage J, Weisenburger D. Diffuse, intermediate, lymphocytic lymphoma: A clinico-pathologic study and comparison with small lymphocytic lymphoma and diffuse, small cleaved cell lymphoma. Cancer 1990;66: 1995-2000.
5. Lardelli P, Bookman M, Sundeen J, Longo D, Jaffe E. Lymphocytic lymphoma of intermediate differentiation: Morphologic and immunophenotypic spectrum and clinical correlations. Am J Surg Pathol 1990;14:752-63.
6. Weisenburger D, Linder J, Daley H, Armitage J. Intermediate lymphocytic lymphoma: An immunohistologic study with comparison to other lymphocytic lymphomas. Hum Pathol 1987;18:781-90.
7. Rappaport H. Tumors of the hematopoietic system. In: Atlas of tumor pathology. Section 3. Fascicle 8. Washington DC: US Armed Forces Institute of Pathology, 1966.
8. Lukes RJ, Collins RD. Immunological characterisation of human malignant lymphomas. Cancer 1974;34:1488-503.
9. Non-Hodgkin's lymphoma. Pathologic classification project. National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: Summary and description of a working formulation for clinical usage. Cancer 1982;49:2112-35.
10. Weisenburger DD, Kim H, Rappaport H. Mantle zone lymphoma: A follicular variant of intermediate lymphocytic lymphoma. Cancer 1982;49:1429-38.
11. Lennert K, Feller AC. Histopathology of non-Hodgkin's lymphomas (based on the updated Kiel classification). 2nd edn. Berlin: Springer Verlag, 1992:101.
12. Kilo MN, Dorfman DM. The utility of flow cytometric immunophenotypic analysis in the distinction of small lymphocytic lymphoma/chronic lymphocytic leukemia from mantle cell lymphoma. Am J Clin Pathol 1996;105:451-7.
13. Jaffe ES, Bookman MA, Longo DL. Lymphocytic lymphoma of intermediate differentiation - Mantle zone lymphoma: A distinct subtype of B-cell lymphoma. Hum Pathol 1987;18:877-80.
14. Berger F, Felman P, Sonet A, Salles G, Bastion Y, Bryon PA, et al. Non-follicular, small, B-cell lymphomas: A heterogeneous group of patients with distinct clinical features and outcome. Blood 1994;83:2829-35.
15. Pittaluga S, Wlodarska I, Stul MS, Thomas J, Verhoef G, Cassiman JJ, et al. Mantle cell lymphoma: A clinicopathological study of 55 cases. Histopathology 1995;26:17-24.
16. Strickler JG, Medeiros J, Copenhaver CM, Weiss LM, Warnke RA. Intermediate lymphocytic lymphoma: An immunophenotypic study with comparison to small lymphocytic lymphoma and diffuse, small cleaved cell lymphoma. Hum Pathol 1988;19:550-4.
17. Zukerberg LR, Medeiros LJL, Ferry JA, Harris NL. Diffuse, low-grade B-cell lymphomas. Four clinically distinct subtypes defined by a combination of morphologic and immunophenotypic features. Am J Clin Pathol 1993;100: 373-85.
18. Cuevas EC, Bateman AC, Wilkins BS, Johnson PA, Williams JH, Lee AHS, et al. Microwave antigen retrieval in immunocytochemistry: A study of 80 antibodies. J Clin Pathol 1994;47:448-52.
19. Merz H, Malisius S, Mannweiler R, Zhou W, Hartman N, Orscheschek K, et al. Methods in laboratory investigation. ImmunoMax. A maximised immunohistochemical method for the retrieval and enhancement of hidden antigens. Lab Invest 1995;73:149-56.
20. Treasure J, Lane A, Jones DB, Wright DH. CD43 expression in B-cell lymphoma. J Clin Pathol 1992;45: 1018-22.
21. Morgan JM, Navabi H, Schmid KW, Jasani B. Possible role of tissue-bound calcium ions in citrate-mediated high-temperature antigen retrieval. J Pathol 1994;174:301 7.
22. Weisenburger DD, Sanger WG, Armitage JO, Purtilo DT. Intermediate lymphocytic lymphoma: Immunophenotypic and cytogenetic findings. Blood 1987;69:1617 21.
23. Frizzera G, Sakurai M, Notohara K, Konishi H. t(11;14) (q13;q32) in B-cell lymphomas (intermediately differentiated lymphocytic and follicular): A report of 4 cases. Am J Clin Pathol 1991;95:684-91.
24. Vandenberghe E, de Wolf-Peeters C, van den Oord J, Wlodarska I, Delabie J, Stul M, et al. Translocation (11;14): A cytogenetic anomaly associated with B-cell lymphomas of non-follicle centre cell lineage. J Pathol 1991;163:13 18.
25. Leroux D, Le Marc'Hadour F, Gressin R, Jacob MC, Keddari E, Monteil M, et al. Non-Hodgkin's lymphomas with t(11;14) (q13;q32): A subset of mantle zone-intermediate lymphocytic lymphoma? Br J Haematol 1991;77:346 53.
26. Swerdlow SH, Yang W-I, Zukerberg LR, Harris NL, Arnold A, Williams ME. Expression of Cyclin D1 protein in centrocytic/mantle cell lymphomas with, and without, rearrangement of the BCL-1/Cyclin D1 gene. Hum Pathol 1995;26:999-1004.
27. Ott MM, Helbing A, Ott G, Bartek J, Fischer L, Dürr A, et al. bel-1 rearrangement and Cyclin D1 protein expression in mantle cell lymphoma. J Pathol 1996;179:238-42.
28. Yang W-I, Zukerberg LR, Motokura T, Arnold A, Harris NL. Cyclin D1 (Bcl-1, PRAD1) protein expression in low-grade B-cell lymphomas and reactive hyperplasia. Am J Pathol 1994;145:86-96.
29. Zukerberg LR, Yang W-I, Arnold A, Harris NL. Cyclin D1 expression in non-Hodgkin's lymphomas. Detection by immunohistochemistry. Am J Clin Pathol 1995;103:756 60.
30. Wilkinson KD, Lee K, Deshpande S, Duerksen-Hughes P, Boss JM, Pohl J. The neuron-specific protein PGP9.5 is a ubiquitin carboxyl-terminal hydrolase. Science 1989;246: 670-3.
31. Langlois NEI, King G, Herriot R, Thompson WD. Non-enzymatic retrieval of antigen permits staining of follicle centre cells by the rabbit polyclonal antibody to protein gene product 9.5. J Pathol 1994;173:249-53.
32. Langlois NEI, King G, Herriot R, Thompson WD. An evaluation of the staining of lymphomas and normal tissues by the rabbit polyclonal antibody to protein gene product 9.5, following non-enzymatic retrieval of antigen. J Pathol 1995;175:433-9.
33. Glotzer M, Murray AW, Kirschner MW. Cyclin is degraded by the ubiquitin pathway. Nature 1991;349:132-8.